Aymen Elfiky

435 total citations
4 papers, 117 citations indexed

About

Aymen Elfiky is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Aymen Elfiky has authored 4 papers receiving a total of 117 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Pulmonary and Respiratory Medicine and 1 paper in Surgery. Recurrent topics in Aymen Elfiky's work include Vascular Tumors and Angiosarcomas (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Renal cell carcinoma treatment (1 paper). Aymen Elfiky is often cited by papers focused on Vascular Tumors and Angiosarcomas (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Renal cell carcinoma treatment (1 paper). Aymen Elfiky collaborates with scholars based in United States. Aymen Elfiky's co-authors include Ravi B. Parikh, Ziad Obermeyer, Barry Fortner, Michael B. Atkins, Jonathan E. Rosenberg, Mei Sheng Duh, David F. McDermott, Toni K. Choueiri, Kristina Chen and William Oh and has published in prestigious journals such as Journal of Clinical Oncology, JAMA Network Open and Urologic Oncology Seminars and Original Investigations.

In The Last Decade

Aymen Elfiky

3 papers receiving 116 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aymen Elfiky United States	3	36	33	31	27	26	4	117
Elena Leinert Germany	8	59 1.6×	40 1.2×	20 0.6×	78 2.9×	69 2.7×	30	235
Melissa Estévez United States	6	24 0.7×	39 1.2×	18 0.6×	45 1.7×	15 0.6×	18	142
Edmund M. Qiao United States	8	18 0.5×	18 0.5×	16 0.5×	84 3.1×	8 0.3×	35	183
Andrew Baer United States	6	18 0.5×	80 2.4×	52 1.7×	101 3.7×	21 0.8×	6	253
Jordan P. McPherson United States	10	10 0.3×	10 0.3×	38 1.2×	92 3.4×	16 0.6×	24	187
Alistair Connell United Kingdom	6	44 1.2×	38 1.2×	23 0.7×	11 0.4×	30 1.2×	9	206
Andrew J. Steele United Kingdom	2	26 0.7×	67 2.0×	10 0.3×	7 0.3×	18 0.7×	2	157
Ross O’Hagan United States	9	31 0.9×	38 1.2×	11 0.4×	17 0.6×	48 1.8×	27	236
Kate Ennis United Kingdom	5	13 0.4×	6 0.2×	15 0.5×	29 1.1×	11 0.4×	10	149
Yu Ri Im United Kingdom	7	61 1.7×	56 1.7×	6 0.2×	36 1.3×	35 1.3×	9	329

Countries citing papers authored by Aymen Elfiky

Since Specialization

Citations

This map shows the geographic impact of Aymen Elfiky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aymen Elfiky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aymen Elfiky more than expected).

Fields of papers citing papers by Aymen Elfiky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aymen Elfiky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aymen Elfiky. The network helps show where Aymen Elfiky may publish in the future.

Co-authorship network of co-authors of Aymen Elfiky

This figure shows the co-authorship network connecting the top 25 collaborators of Aymen Elfiky. A scholar is included among the top collaborators of Aymen Elfiky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aymen Elfiky. Aymen Elfiky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Uzzo, Robert G., Rituparna Bhattacharya, Manojkumar Bupathi, et al.. (2025). Real-world analysis of pembrolizumab utilization and characteristics of patients being prescribed treatment in early stage RCC.. Journal of Clinical Oncology. 43(5_suppl). 480–480.

2.

Elfiky, Aymen, et al.. (2018). Development and Application of a Machine Learning Approach to Assess Short-term Mortality Risk Among Patients With Cancer Starting Chemotherapy. JAMA Network Open. 1(3). e180926–e180926. 107 indexed citations

3.

Elfiky, Aymen. (2015). Adrenocortical Carcinoma. Surgical pathology clinics. 8(4). 751–754. 4 indexed citations

4.

Elfiky, Aymen, Daniel C. Cho, David F. McDermott, et al.. (2010). Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 29(6). 756–763. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact